Imported severe malaria and risk factors for intensive care: A single-centre retrospective analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 13 06 2019
accepted: 29 10 2019
entrez: 15 11 2019
pubmed: 15 11 2019
medline: 25 3 2020
Statut: epublish

Résumé

This study aims to identify the risk factors for intensive care (IC) in severe malaria patients admitted to the "Lazzaro Spallanzani" National Institute for Infectious Diseases, Rome, Italy. All patients with confirmed severe malaria and hospitalized between 2007 and 2015 were included in the analysis and stratified into two groups: those requiring IC and those who did not. Five prognostic malaria scores were estimated; clinical severity at IC unit admission was assessed using the Sequential Organ Failure Assessment and the quick-Sequential Organ Failure Assessment scores. Univariate and multivariate analysis were performed to assess factors independently associated to IC. A total of 98 severe malaria patients were included; 10 of them required IC. There were no deaths or sequelae. Patients requiring IC had higher severity scores. At the multivariate analysis, only the number of World Health Organization criteria and the aspartate aminotransferase value were independently associated with the need of IC. An early and accurate assessment of the severity score is essential for the management of severe malaria patients.

Identifiants

pubmed: 31725774
doi: 10.1371/journal.pone.0225135
pii: PONE-D-19-16792
pmc: PMC6855647
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0225135

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Trans R Soc Trop Med Hyg. 1994 May-Jun;88(3):314
pubmed: 7974674
Med Mal Infect. 2020 Mar;50(2):213-225
pubmed: 30266432
Lancet Infect Dis. 2017 Jan;17(1):98-107
pubmed: 27777030
Lancet. 2010 Nov 13;376(9753):1647-57
pubmed: 21062666
Clin Infect Dis. 1998 Jul;27(1):142-9
pubmed: 9675468
J Assoc Physicians India. 2009 Feb;57:119-26
pubmed: 19582979
PLoS One. 2010 Oct 08;5(10):e13236
pubmed: 20949045
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
Lancet. 2005 Aug 27-Sep 2;366(9487):717-25
pubmed: 16125588
Br J Anaesth. 2014 Dec;113(6):910-21
pubmed: 24946778
Ann Intern Med. 1990 Aug 15;113(4):326-7
pubmed: 2197915
J Assoc Physicians India. 2014 Jan;62(1):14-7
pubmed: 25327086
Acta Trop. 2015 Jun;146:152-6
pubmed: 25820030
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Malar J. 2007 Feb 27;6:24
pubmed: 17326839
Clin Infect Dis. 2010 Mar 1;50(5):679-85
pubmed: 20105074

Auteurs

Alessandra D'Abramo (A)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Luciana Lepore (L)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Marco Iannetta (M)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Saba Gebremeskel Tekle (S)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Angela Corpolongo (A)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Laura Scorzolini (L)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Nazario Bevilacqua (N)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Andrea Mariano (A)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Maria Letizia Giancola (ML)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Antonella Vulcano (A)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Micaela Maritti (M)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Alessandro Agresta (A)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Mario Antonini (M)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Umberto D'Alessandro (U)

MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, The Gambia.

Emanuele Nicastri (E)

National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH